Your browser doesn't support javascript.
loading
Staging and clean room: Constructs designed to facilitate transparency and reduce bias in comparative analyses of real-world data.
Muntner, Paul; Hernandez, Rohini K; Kent, Shia T; Browning, James E; Gilbertson, David T; Hurwitz, Kathleen E; Jick, Susan S; Lai, Edward C; Lash, Timothy L; Monda, Keri L; Rothman, Kenneth J; Bradbury, Brian D; Brookhart, M Alan.
Afiliação
  • Muntner P; Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Hernandez RK; Center for Observational Research, Amgen Inc., Thousand Oaks, California, USA.
  • Kent ST; Center for Observational Research, Amgen Inc., Thousand Oaks, California, USA.
  • Browning JE; Center for Observational Research, Amgen Inc., Thousand Oaks, California, USA.
  • Gilbertson DT; Chronic Disease Research Group, Hennepin Healthcare Research Institute, Minneapolis, Minnesota, USA.
  • Hurwitz KE; Target RWE, Durham, North Carolina, USA.
  • Jick SS; Boston Collaborative Drug Surveillance Program, Boston University School of Public Health, Boston, Massachusetts, USA.
  • Lai EC; School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Lash TL; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.
  • Monda KL; Center for Observational Research, Amgen Inc., Thousand Oaks, California, USA.
  • Rothman KJ; RTI Health Solutions, Research Triangle Institute, Research Triangle Park, North Carolina, USA.
  • Bradbury BD; Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts, USA.
  • Brookhart MA; Center for Observational Research, Amgen Inc., Thousand Oaks, California, USA.
Pharmacoepidemiol Drug Saf ; 33(3): e5770, 2024 Mar.
Article em En | MEDLINE | ID: mdl-38419140
ABSTRACT

PURPOSE:

We describe constructs designed to protect the integrity of the results from comparative analyses using real-world data (RWD) staging and clean room.

METHODS:

Staging involves performing sequential preliminary analyses and evaluating the population size available and potential bias before conducting comparative analyses. A clean room involves restricted access to data and preliminary results, policies governing exploratory analyses and protocol deviations, and audit trail. These constructs are intended to allow decisions about protocol deviations, such as changes to design or model specification, to be made without knowledge of how they might affect subsequent analyses. We describe an example for implementing staging with a clean room.

RESULTS:

Stage 1 may involve selecting a data source, developing and registering a protocol, establishing a clean room, and applying inclusion/exclusion criteria. Stage 2 may involve attempting to achieve covariate balance, often through propensity score models. Stage 3 may involve evaluating the presence of residual confounding using negative control outcomes. After each stage, check points may be implemented when a team of statisticians, epidemiologists and clinicians masked to how their decisions may affect study outcomes, reviews the results. This review team may be tasked with making recommendations for protocol deviations to address study precision or bias. They may recommend proceeding to the next stage, conducting additional analyses to address bias, or terminating the study. Stage 4 may involve conducting the comparative analyses.

CONCLUSIONS:

The staging and clean room constructs are intended to protect the integrity and enhance confidence in the results of analyses of RWD.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Políticas Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Políticas Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article